208 related articles for article (PubMed ID: 25597749)
1. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
[TBL] [Abstract][Full Text] [Related]
2. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
4. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
[TBL] [Abstract][Full Text] [Related]
5. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
8. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 and colorectal cancer.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Br J Cancer; 1999 Mar; 79(9-10):1494-9. PubMed ID: 10188896
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
11. Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer.
Özdemir E; Çiçek T; Kaya MO
Urol J; 2012; 9(3):568-73. PubMed ID: 22903479
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 levels and atrial fibrillation in the general population.
Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
[TBL] [Abstract][Full Text] [Related]
13. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
16. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
[TBL] [Abstract][Full Text] [Related]
17. YKL-40 protein correlates with the phenotype of asthma.
Specjalski K; Chełmińska M; Jassem E
Lung; 2015 Apr; 193(2):189-94. PubMed ID: 25663327
[TBL] [Abstract][Full Text] [Related]
18. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†).
Hvolris MH; Piper TB; Hammer E; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Christensen IJ; Brünner N; Johansen JS; Davis GJ; Dowell BL; Nielsen HJ
Scand J Gastroenterol; 2016 Jul; 51(7):860-5. PubMed ID: 26918701
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the inflammatory protein YKL-40 in precancers of the breast.
Qin W; Zhu W; Schlatter L; Miick R; Loy TS; Atasoy U; Hewett JE; Sauter ER
Int J Cancer; 2007 Oct; 121(7):1536-42. PubMed ID: 17565739
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
